Home / Healthcare / Pulmonary Inflammation Global Clinical Trials Review, H2, 2015

Pulmonary Inflammation Global Clinical Trials Review, H2, 2015

Published: Nov 2015 | No Of Pages: 43 | Published By: GlobalData

Pulmonary Inflammation Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Pulmonary Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Pulmonary Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Asthma Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Asthma 31
Nov 05, 2015: Completion of patient enrolment in two RPL554 Phase IIa studies, ahead of expected timeline 31
Nov 04, 2015: Teva to Present Phase III data on Reslizumab at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology 31
Nov 04, 2015: Teva to Present Abstract on ProAir RespiClick at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology 32
Nov 02, 2015: Invion Announces Full Enrolment of NIH- Sponsored Asthma Trial 32
Oct 27, 2015: GSK’s Advair Diskus achieves primary endpoint in LABA safety study of patients with asthma 32
Sep 30, 2015: Positive Data Presented on Pieris Pharmaceuticals' Inhaled Asthma Program at ERS and Company Strengthens Management Team 33
Sep 27, 2015: Teva Presents New Reslizumab Data at European Respiratory Society International Congress 2015 34
Sep 24, 2015: Cempra to Present Solithromycin Data in COPD Patient Subgroup at European Respiratory Society International Congress 35
Sep 21, 2015: ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio - new data on Spiolto Respimat for COPD treatment 35
Sep 21, 2015: ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio - new data on Spiriva Respimat for asthma treatment 36
Clinical Trial Profile Snapshots 37
Appendix 1582
Abbreviations 1582
Definitions 1582
Research Methodology 1583
Secondary Research 1583
About GlobalData 1584
Contact Us 1584
Disclaimer 1584
Source 1585

Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Region, 2015* 5
Pulmonary Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Pulmonary Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8
Pulmonary Inflammation Therapeutics Clinical Trials, Europe, Top Countries, 2015* 9
Pulmonary Inflammation Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Proportion of Pulmonary Inflammation to Respiratory Clinical Trials, G7 Countries (%), 2015* 11
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 12
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Phase, 2015* 14
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 15
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015* 16
Pulmonary Inflammation Therapeutics Clinical Trials, Global, by End Point Status, 2015* 17
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 18
Pulmonary Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 19
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 21
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 23
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24

Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Pulmonary Inflammation Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Pulmonary Inflammation Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8
Pulmonary Inflammation Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 9
Pulmonary Inflammation Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Proportion of Pulmonary Inflammation to Respiratory Clinical Trials, G7 Countries (%), 2015* 11
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 12
Pulmonary Inflammation Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 13
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Phase (%), 2015* 14
Pulmonary Inflammation Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 15
Pulmonary Inflammation Therapeutics, Global, Clinical Trials by Trial Status, 2015* 16
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 18
Pulmonary Inflammation Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 19
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 20
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 22
Pulmonary Inflammation Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
GlobalData Methodology 41

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +